+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Animal Health Active Pharmaceutical Ingredients Market (2021-2026) by Business, Indication, Synthesis, Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5397317
  • Report
  • May 2021
  • Region: Global
  • 189 pages
  • Infogence Global Research
UP TO OFF
until Nov 30th 2021
The Global Animal Health Active Pharmaceutical Ingredients Market is Estimated to Be USD 16.12 Bn in 2021 and is Expected to Reach USD 23.63 Bn by 2026, Growing at a CAGR of 7.95%

FEATURED COMPANIES

  • Eli Lilly & Co
  • Excel Industries Ltd
  • Huvepharma
  • Indukern, S.A
  • Lonza Group AG
  • NGL Fine Chem Ltd
  • MORE
The Global Animal Health Active Pharmaceutical Ingredients Market is estimated to be USD 16.12 Bn in 2021 and is expected to reach USD 23. 63 Bn by 2026, growing at a CAGR of 7.95%.



Market Dynamics

The global animal health active pharmaceutical ingredients market is being driven by increasing animal healthcare infrastructure and facilities, rising focus on animal well-being, an increase in the number of animal healthcare NGOs, increased pet adoption, and unmet medical needs. In addition, as the economies are growing, more governments and pharmaceutical firms are investing in animal healthcare, and the rising research and development activities and the growing focus on innovations are projected to offer lucrative growth opportunities for the growth of global animal health active pharmaceutical ingredients market.

However, the market's development is being restrained by rising costs and the Government's regulatory prohibitions on the animal pharmaceuticals industry.

Market Segmentation

The Global Animal Health Active Pharmaceutical Ingredients Market is segmented further based on Business, Indication, Synthesis, Type, End-User, and Geography.

By Business, the market is classified into captive API and merchant API. Amongst the two, the captive APIsegment is estimated to hold the highest market share during the forecast period.

By Indication, the market is classified as anti-infective, antiparasitics, and NSAIDS & anesthetics. Amongst all, the anti-infective segment is estimated to hold the highest market share during the forecast period.

By Synthesis, the market is classified as biotech and synthetic. Amongst the two, the biotech segment is estimated to hold the highest market share during the forecast period.

By Type, the market is classified as branded and generic. Amongst the two, the branded segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified as pet care hospitals, retail, and specialty pharmacies. Amongst all, the pet care hospitals segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. INROADS partners with Zoetis for diversity opportunities in animal health. - 9th February 2021.
2. Olon S.p.A., a world-leading active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced Capua BioServices S.p.A., a global provider of CDMO services in the field of microbial fermentation.- 25th January 2019.

Company Profiles

Some of the companies covered in this report are Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co Ltd, Eli Lilly & Co, Excel Industries Ltd, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global Animal Health Active Pharmaceutical Ingredients Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Eli Lilly & Co
  • Excel Industries Ltd
  • Huvepharma
  • Indukern, S.A
  • Lonza Group AG
  • NGL Fine Chem Ltd
  • MORE
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook

4 Market Influencers
4.1 Drivers
4.1.1 Increasing Adoption of Pets
4.1.2 Increase in the Number of Animal Healthcare NGOs
4.2 Restraints
4.2.1 Risk Associated with Animal Health APIs
4.2.2 High Investment
4.3 Opportunities
4.3.1 Growing Research and Development for New Products
4.4 Challenges
4.4.1 Limited Awareness Towards Animal Health
4.5 Trends

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Animal Health Active Pharmaceutical Ingredients Market, By Business
6.1 Introduction
6.2 Captive API
6.3 Merchant API

7 Global Animal Health Active Pharmaceutical Ingredients Market, By Indication
7.1 Introduction
7.2 Anti-infectives
7.3 Antiparasitic
7.4 NSAIDs & Anesthetics

8 Global Animal Health Active Pharmaceutical Ingredients Market, By Synthesis
8.1 Introduction
8.2 Biotech
8.3 Synthetic

9 Global Animal Health Active Pharmaceutical Ingredients Market, By Type
9.1 Introduction
9.2 Branded
9.3 Generic

10 Global Animal Health Active Pharmaceutical Ingredients Market, By End User
10.1 Introduction
10.2 Pet Care Hospitals
10.3 Retail
10.4 Specialty pharmacies

11 Global Animal Health Active Pharmaceutical Ingredients Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 South America
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Chile
11.3.4 Colombia
11.4 Europe
11.4.1 UK
11.4.2 France
11.4.3 Germany
11.4.4 Italy
11.4.5 Spain
11.4.6 Netherlands
11.4.7 Sweden
11.4.8 Russia
11.4.9 Rest of Europe
11.5 Asia-Pacific
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Indonesia
11.5.5 Malaysia
11.5.6 South Korea
11.5.7 Australia
11.5.8 Sri Lanka
11.5.9 Thailand
11.5.10 Rest of APAC
11.6 Middle-East and Africa
11.6.1 Qatar
11.6.2 Saudi Arabia
11.6.3 South Africa
11.6.4 United Arab Emirates

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 Blanver Farmoquimica E Farmaceutica S.A
13.2 Changzhou Yabang-Qh Pharmachem Co., Ltd
13.3 Eli Lilly & Co
13.4 Excel Industries Ltd
13.5 Glenmark Pharmaceutical Ltd.
13.6 Huvepharma
13.7 Indukern, S.A
13.8 Lonza Group AG
13.9 NGL Fine Chem Ltd
13.10 Ningxia Tairui Pharma CO. Ltd
13.11 Ofichem BV
13.12 Omkar Speciality Chemicals Limited
13.13 Ourofino Saúde Animal
13.14 P&R SpA (Olon SpA)
13.15 Sanofi Winthrop Industrie (CEPiA)
13.16 Sequent Scientific Ltd
13.17 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
13.18 Shanghai Pharmtech Co. Ltd
13.19 Zhejiang Hisun Pharmaceutical Co. Ltd
13.20 Zoetis Inc.

14 Appendix
14.1 Questionnaire
Note: Product cover images may vary from those shown
  • Blanver Farmoquimica E Farmaceutica S.A
  • Changzhou Yabang-Qh Pharmachem Co., Ltd
  • Eli Lilly & Co
  • Excel Industries Ltd
  • Glenmark Pharmaceutical Ltd.
  • Huvepharma
  • Indukern, S.A
  • Lonza Group AG
  • NGL Fine Chem Ltd
  • Ningxia Tairui Pharma CO. Ltd
  • Ofichem BV
  • Omkar Speciality Chemicals Limited
  • Ourofino Saúde Animal
  • P&R SpA (Olon SpA)
  • Sanofi Winthrop Industrie (CEPiA)
  • Sequent Scientific Ltd
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
  • Shanghai Pharmtech Co. Ltd
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Zoetis Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll